ZE46-0134
ZE46-0134-0002
Phase 1 small_molecule active
Quick answer
ZE46-0134 for AML With Gene Mutations is a Phase 1 program (small_molecule) at Lomond Therapeutics Holdings with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Lomond Therapeutics Holdings
- Indication
- AML With Gene Mutations
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active